Institute for Stem Cell Science and Regenerative Medicine (DBT-inStem)

Research at DBT-inStem addresses the genetic mechanisms of potency, differentiation and proliferation in human pluripotent cells, examines clinical manifestations of diseases that can potentially be treated by stem cells, models human diseases using stem cells, uses model organisms such as Planaria and Hydra to address fundamental questions in regenerative biology, develops platforms to interrogate signaling pathways with new chemical entities, and finally, develops tools that will help to better understand the biology driving stem cells and eventually treat disease states. At DBT-inStem, research is primarily carried out by groups who work on tightly-knit themes, crossing boundaries and developing new approaches...

Brain development and repair,cardiovascular biology,cardiovascular diseases,chemical biology,therapeutics,cell fate regulation,infllamation,tissue homeostasis,technologies for advancement of science,stem cell,brain disorders,mental health,disease biology,neurosciences,biochemistry,biophysics,genetics,structural biology,clinical sciences,computational biology,and cardiomyopathy

Institute for stem cell science and regenerative medicine (dbt-instem) operates in the Research services industry.

Institute for stem cell science and regenerative medicine (dbt-instem)'s revenue is 11m - 100m

Institute for stem cell science and regenerative medicine (dbt-instem) has 201 - 500 employees.